ClinicalTrials.gg
Not yet recruitingNCT07672886Updated Jun 29, 2026

Parents' Knowledge and Attitudes Towards Vaccinating Their Children

An interventional study of questionnaire application in Vaccine Hesitancy, sponsored by Iuliu Hatieganu University of Medicine and Pharmacy. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-29.

Sponsored by Iuliu Hatieganu University of Medicine and Pharmacy · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Jul 2026, 4 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Purpose: To identify and evaluate the factors that influence parents' attitudes towards vaccination.

Objectives:

  1. To assess parents' level of knowledge about vaccines
  2. To assess parents' attitudes and behavior regarding vaccine administration.
  3. To observe whether there is a link between various socio-demographic factors and their knowledge about vaccines.
  4. To assess the relationship and communication between doctors and parents.
  5. To evaluate the influence of the COVID-19 pandemic on parents' trust in vaccines.

Method Distribution of questionnaires to parents of patients under 18 years of age admitted in the Emergency Children's Hospital, Cluj-Napoca, Paediatrics Clinic III. Collection of clinical data by applying questionnaires completed voluntarily by parents

Read the detailed description

Parents' knowledge and attitudes towards vaccinating their children

Introduction Vaccines administered in childhood save 2-3 million lives globally each year. They have contributed substantially to the decline in infant morbidity and mortality rates over time and represent the most cost-effective method of reducing childhood illness.

A high vaccination rate among the population protects both those who have received the vaccine and those who have not, through the phenomenon of herd immunity. Maintaining protection plays an important role in the development of the paediatric population. Early childhood infections can affect the growth and development of children, impacting the health and cognitive abilities of future adults. Although vaccines reduce morbidity and mortality, many parents do not vaccinate their children. In developing countries, the main causes of non-vaccination are low socio-economic status, poor parental education and limited access to medical services. On the other hand, in more developed countries, parents, despite having easy access to vaccines and information, choose not to vaccinate their children.

In order to increase vaccination rates, it is necessary to understand where parents' beliefs come from. Parents' refusal to vaccinate their children has been associated with: the costs involved in the vaccination process, fear of adverse effects, both immediate and long-term, the belief that vaccines are ineffective, and various attitudes. These include: lack of trust in the state authorities responsible for implementing vaccination programmes, religious conflicts, and the idea of over stimulating the child's immune system with "too many vaccines".

Recently, a decisive factor has emerged that influences parents' opinions: social media. Studies conducted to date have shown the impact of anti-vaccine content posted online on the decline in vaccination rates.

Hypothesis: The decline in vaccination rates among the paediatric population is occurring in both developed countries and low socio-economic environments, with parental attitudes being the main decisive factor.

Purpose: To identify and evaluate the factors that influence parents' attitudes towards vaccination.

Objectives:

  1. To assess parents' level of knowledge about vaccines
  2. To assess parents' attitudes and behavior regarding vaccine administration.
  3. To observe whether there is a link between various socio-demographic factors and their knowledge about vaccines.
  4. To assess the relationship and communication between doctors and parents.
  5. To evaluate the influence of the COVID-19 pandemic on parents' trust in vaccines.

Research area: research into parents' attitudes and knowledge about vaccines and their interaction with healthcare professionals.

Study type: descriptive, cross-sectional, representative sample study. Target population: parents of children under 18 years of age evaluated at the Emergency Children's Hospital, Cluj-Napoca, Paediatrics Clinic III, between January- Sept 2026.

Representative sample data collection

Materials and methods:

Distribution of questionnaires to parents of patients under 18 years of age admitted in the Emergency Children's Hospital, Cluj-Napoca, Paediatrics Clinic III. Collection of clinical data by applying questionnaires completed voluntarily by parents. By completing the informed consent form, parents gave their consent to participate in this study.

Clinical data to be recorded: gender, age, place of residence, level of education, profession, age of children, vaccination status of parents and children. Collection of data on: parents' knowledge and attitudes towards vaccines, the doctor-parent relationship and parents' level of trust in doctors, and knowledge about infections. Distribution of questionnaires to family doctors and paediatricians to assess the communication relationship between doctors and parents in the context of vaccines.

Descriptive statistics: Data will be stored in accordance with legal provisions for the protection of patients' identity and personal data. Statistical analysis of the data will be performed using Microsoft Excel and SPSS.

The results and conclusions will be disseminated through the publication of articles in scientific journals.

02

Conditions studied

  • Vaccine Hesitancy

Browse trials for

03

In context

Vaccination Hesitancy

121 studies on the registry are indexed under Vaccination Hesitancy; 14 are open to participants now.

This study's planned enrollment of 200 is below the median of 516 across 98 interventional studies indexed under Vaccination Hesitancy.

Browse Vaccination Hesitancy studies →

Lead sponsor

Iuliu Hatieganu University of Medicine and Pharmacy is the lead sponsor of 56 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

- parents of patients under 18 years of age admitted to the Emergency Children's Hospital, Cluj-Napoca, Paediatrics Clinic III during January -sept 2026

Exclusion criteria

Exclusion Criteria:

- parent of patients under 18 years who refuse to participate or to fill in the questionnaire and the consent form

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Parents questionaires

    Distribution of questionnaires to parents of patients under 18 years of age admitted in the Emergency Children's Hospital, Cluj-Napoca

    Other: questionnaire application

Interventions

  • Otherquestionnaire application

    questionnaire application

06

What researchers measure

Primary outcomes

  1. The questionnaire administered to parents and caregivers, entitled "Parents' Knowledge and Attitudes Toward Childhood Vaccination", was designed to identify the factors influencing vaccine acceptance, hesitancy, and refusal.

    The questionnaire items were structured into the following main domains: Sociodemographic characteristics Vaccination status Attitudes and motivations Sources of information and trust Data obtained from the questionnaires will be analysed. The distribution of quantitative variables will be assessed using the Shapiro-Wilk test. Categorical variables will be expressed as absolute frequencies and percentages. Associations between categorical variables were evaluated using the Chi-square test. Comparisons of non-parametric quantitative variables between two independent groups were performed using the Mann-Whitney U test.

    Time frame: bseline

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jul 2026; primary completion for Jul 2026, 0 months later.

Of 82 non-industry interventional studies with no phase under Vaccination Hesitancy, half reached primary completion within 6 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 14. This study's planned 0 months is below that.

Counting every sponsor, half of 83 studies reached it within 5 months; a quarter within 2 and three quarters within 14.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 26, 2026
First posted
Jun 29, 2026
StartEst.
Jul 1, 2026
Primary completionEst.
Jul 1, 2026
CompletionEst.
Jul 1, 2026
Last update
Jun 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07672886
Lead sponsor
Iuliu Hatieganu University of Medicine and Pharmacy
Responsible party
Sas Valentina (Assistant Professor, Iuliu Hatieganu University of Medicine and Pharmacy) — Principal investigator
First posted
Jun 29, 2026
Start date
Jul 1, 2026 (estimated)
Primary completion
Jul 1, 2026 (estimated)
Completion
Jul 1, 2026 (estimated)
Last update
Jun 29, 2026

Study contacts

Valentina Sas
Contact
sas.valentina@umfcluj.ro
+40740139979

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion